Researchers reported that FOSL1, a component of AP-1 transcription factor complexes, was a key player in regulating PMT. FOSL1 was predominantly expressed in the mesenchymal subtype, but not proneural subtype of glioblastoma stem cells.
[Molecular Therapy]